AtriCure ATRC 深 沪
等待开盘 11-13 09:30:00 美东时间
55.98
-1.550
-2.69%
华盛通- 最 高58.235
- 今 开57.93
- 成交量 46.25万股
- 最 低 55.74
- 昨 收 57.53
- 总市值 28.51亿
- 52周最高 66.02
- 市盈率 静 --
- 换手率 0.91%
- 52周最低 25.36
- 委 比 -59.92%
- 总股本 5092.23万
- 历史最高 89.18
- 量 比 0.55
- 振 幅 4.34%
- 历史最低 5.90
- 每 手 1
- 风险率 10.76%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 可口可乐、麦当劳、3M等获多家大行看好；机构上调高通目标价至165美元
今日重点评级关注：Citizens：维持Precigen"跑赢大市"评级，目标价从11美元升至12美元；Leerink Partners：维持Arcus Biosciences"跑赢大市"评级，目标价从46美元升至49美元
11-06 16:15
美股大行评级 | 大摩上调AMD目标价至725美元；安进、多邻国绩后获华尔街大行看多
今日重点评级关注：康托·菲茨杰拉德：维持Supernus"超配"评级，目标价从67美元升至87美元；丰业银行：维持Atlas Energy Solutions"跑赢大市"评级，目标价从17美元升至18美元
11-05 14:06
Block To Rally Around 54%? Here Are 10 Top Analyst Forecasts For Wednesday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Piper Sandler raised the price target for Freshworks Inc (NASDAQ:FRSH) from $12 to $15. Piper Sandler analyst ...
11-04 20:39
AtriCure Analysts Boost Their Forecasts After Better-Than-Expected Q3 Results
AtriCure, Inc. (NASDAQ:ATRC) on Tuesday posted upbeat results for the third quarter. The company reported quarterly earnings of 17 cents per share which beat the analyst consensus estimate of a loss of 5 cents per share. The company reported quarterly sales of $154.450 million which beat the analyst...
11-04 18:36
BTIG Maintains Buy on AtriCure, Raises Price Target to $70
BTIG analyst Marie Thibault maintains AtriCure (NASDAQ:ATRC) with a Buy and raises the price target from $63 to $70.
11-04 18:04
AtriCure Raises FY2026 GAAP EPS Guidance from $0.05-$0.13 to $0.21-$0.27 vs $0.14 Est
AtriCure (NASDAQ:ATRC) raises FY2026 GAAP EPS guidance from $0.05-$0.13 to $0.21-$0.27 vs $0.14 analyst estimate..
11-04 05:03
AtriCure Raises FY2026 Adj EPS Guidance from $0.24-$0.32 to $0.40-$0.46 vs $0.15 Est; Raises FY2026 Sales Guidance from $602.000M-$610.000M to $606.000M-$610.000M vs $606.219M Est
AtriCure (NASDAQ:ATRC) raises FY2026 Adj EPS guidance from $0.24-$0.32 to $0.40-$0.46 vs $0.15 analyst estimate. Raises FY2026 sales outlook from $602.000 million-$610.000 million to $606.000 million-$610.000 million vs $606.219 million estimate.
11-04 05:02
美股大行评级 | 潜在涨幅227.21%！Jones Trading上调Rapport Therapeutics(RAPP)目标价至82美元，维持"买入"评级
今日重点评级关注：Jones Trading：维持Rapport Therapeutics"买入"评级，目标价从50美元升至82美元；摩根大通：维持SpaceX"超配"评级，目标价从240美元升至500美元
10-22 11:59
Citizens Maintains Market Outperform on AtriCure, Raises Price Target to $68
Citizens analyst Daniel Stauder maintains AtriCure (NASDAQ:ATRC) with a Market Outperform and raises the price target from $52 to $68.
10-21 21:06
美股大行评级 | 潜在涨幅386.16%！摩根士丹利维持TeraWulf"超配"评级，上调目标价至65美元
今日重点评级关注：摩根士丹利：维持TeraWulf"超配"评级，目标价从62.5美元升至65美元；摩根士丹利：维持Hut 8"超配"评级，目标价从273美元升至275美元
10-13 12:30
